CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenues:
Obstructive sleep apnea (OSA)	$ 99,083	$ 125,007	$ 449,650	$ 460,699
Total revenues	99,083	125,007	449,650	460,699
Costs and expenses:
Costs of revenues	46,028	68,739	280,372	191,770
General and administrative	409,419	484,220	1,396,478	1,582,624
Depreciation	149		449
Total costs and expenses	455,596	552,959	1,677,299	1,774,394
Loss from operations	(356,513)	(427,952)	(1,227,649)	(1,313,695)
Other income (expense):
Interest expense	(307,922)	(381,021)	(1,148,795)	(1,105,563)
Legal settlement			328,269	(17,031)
Settlement of prior accounting services			(240,000)
Extinguishment of loan due to shareholder			7,771,140
Other income			2,380
Total other income (expense)	(307,922)	(381,021)	6,712,994	(1,122,594)
Income taxes
Net income (loss)	$ (664,435)	$ (808,973)	$ 5,485,345	$ (2,436,289)
PER SHARE INFORMATION
Net Income (Loss) Per Common Share (in dollars per share)	$ (0.01)	$ (0.01)	$ 0.08	$ (0.04)
Weighted Average Number of Common Shares Outstanding (in shares)	66,661,656	63,063,685	65,849,175	63,063,685